Crux is an innovation-driven research, design and development consultancy that develops intelligent and beautiful products for some of the biggest brands in the medical, consumer and technology sectors. Our multidisciplinary team of designers, engineers, electronics and software specialists work together to tackle the toughest briefs and deliver innovations that will perform in the real world.
EMERGO by UL, formally known as UL-Wiklund, is a highly experienced human factors team that specializes in user research (including usability testing) and user interface design. Our consulting team has deep experience in the medical device and combination product domains. In addition, it serves several other industries helping to ensure that consumer products, industrial products, software applications, and automotive products deliver a great user experience.
Founded in 1991, Design Science was one of the first consultancies to focus on the person/product interface for medical device design. We have deep roots in those product categories where usability is mission critical— particularly medical devices. We are retained by product-development teams to improve the usability, safety, and customer appeal of products. We creatively apply technical expertise from a variety of engineering, social-science, and design disciplines to support this mission.
CSS (Connecticut Spring & Stamping) is an advanced manufacturing company with more than 75 years of success. We engineer and manufacture precision metal springs, stampings, metal forms and assemblies, especially for the medical device industry. Our experience ranges from auto-injectors and wearable infusion devices, to instruments and sensors. We are ISO13485 certified. Leading OEMs and contract manufacturers partner with CSS for consistent volume production.
LGC is an international leader in life sciences. Our products and services are designed to improve human healthcare and cover development of medicines from small molecule NCEs to therapeutic proteins, antibodies and other biopharmaceuticals, with experience in all major therapeutics areas and routes of administration. Our services range from development, validation and application of bioanalytical methods for small and large drug molecules and biomarkers, to full analytical and physical characterisation support for pharmaceutical product development.
IMA Automation North America designs and builds turn-key assembly and test systems for the medical device industry. Our engineered solutions support your assembly and test projects at every stage in the product life cycle. As part of the IMA Automation Group we offer local solutions for our global customers. From concept to prototyping, clinicals to commercialization, low to high volume production, we have the comprehensive experience and know-how to help you achieve your production goals.
Offering over 55,000 products – and custom designed solutions – C&K’s used to solve the hardest engineering challenges faced in medical devices today. For over 80 years, leading designers, manufacturers and distributors have turned to C&K when they require mission-critical reliability in an electromechanical switch, high-rel connector or custom assemblies. The reason they keep coming back is because C&K’s innovative design, cutting-edge production process, and strict quality assurance standards produce the world’s best switches and components.
PCI Pharma Services is an integrated full service provider, offering unparalleled expertise and experience in taking compounds from the earliest stages of development through to successful commercialization. PCI’s specialized packaging solutions support unique drug delivery systems, including automated assembly and precise on-line verification of injection device components. On-line inspection systems ensure accuracy and correctness of kit contents including various gauge needles, sterile water for injection, safety devices, dosing instructions and instructions for use (IFU), and regulatory literature.
Halozyme is a clinical-stage biotechnology company focused on developing novel cancer therapies, as well as partnering our proprietary ENHANZE® drug delivery technology, which is anchored on our recombinant human hyaluronidase PH20 enzyme (rHuPH20). By rapidly depolymerizing hyaluronan at the injection site, rHuPH20, when administered with our partner’s injectable therapeutics, may remove traditional subcutaneous volume limitations and enable conversion from intravenous to subcutaneous delivery. This can potentially reduce overall administration time and the treatment burden for patients and their caregivers.
Lifecore Biomedical, LLC, is a leader in cGMP-compliant aseptic filling and manufacturing development of difficult to fill, high viscosity pharmaceuticals. Lifecore supports the clinical development and commercialization efforts of its partners by providing customized formulation, filling, and packaging services for pre-clinical development to commercial production.